Author

admin

Browsing

There’s always a lot of hype surrounding the NBA’s trade deadline, and sometimes the speculation ends up becoming reality.

Last year, for instance, the weeks surrounding this de facto league holiday delivered all kinds of transactional fireworks. Luka Doncic, Anthony Davis, Jimmy Butler, De’Aaron Fox and Brandon Ingram were among the notable players to switch teams, and the reverberations from those deals can still be felt now. But two years ago, none of the stars rumored to be on the trading block at the deadline were dealt and only a group of role players wound up changing teams.

So the 2026 NBA trade deadline, scheduled for Feb. 5 at 3 p.m. ET, is poised for more landscape-shifting moves based on names being rumored as possibly available during the opening few months of the 2025-26 regular season. Or it could yield mostly ancillary trades with the NBA’s salary cap limiting how many teams can chase after high-priced stars. It depends what reports you believe.

With that in mind, USA TODAY Sports picked one player from every NBA team that could be traded around the trade deadline next month. The selections are based on public trade reports and speculation, contracts and salary cap considerations, as well as the likelihood a deal is made before the NBA trade deadline arrives.

Players like Trae Young and Davis are included in this exercise for those reasons, while rumored trade targets such as Giannis Antetokounmpo, Ja Morant and LaMelo Ball are not. There are also a wide range of salaries represented depending on a team’s needs and current roster.

Here’s one player from all 30 NBA teams who could be dealt as part of the 2026 NBA trade deadline:

Trae Young, Atlanta Hawks

Speculation about Young’s future had been increasing throughout the start to this season and recent reports indicate Young and the Hawks are working together on a trade ahead of the deadline. Atlanta didn’t win any of the five games Young played after returning from injury last month and the Hawks front office seems ready to move on with Jalen Johnson as its leading star. Young could be the biggest star available at this year’s trade deadline, but his contract and defensive liabilities will limit his list of suitors.

Anfernee Simons, Boston Celtics

A month ago, Simons appeared a likely trade candidate with an inconsistent role on a new team and an expiring contract. But the Celtics now sit in third in the Eastern Conference standings, right as Simon’s play is on the uptick and a potential Jayson Tatum return draws closer. Simons might be better than any trade deadline addition Boston can make, but a big move would almost certainly involve his $27 million salary.

Michael Porter Jr., Brooklyn Nets

Porter is averaging career highs in points and 3-pointers while playing a leading role for the rebuilding Nets, but his experience as a role player for the Denver Nuggets in years past could make him a coveted trade piece at the deadline to teams looking for another offensive weapon.

Coby White, Chicago Bulls

The Bulls are once again treading water in the Eastern Conference, but they could be active at the trade deadline this year with a collection of expiring contracts. White is the biggest target for point guard-needy teams like the Minnesota Timberwolves, though Ayo Dosunmu might be an enticing consolation prize. Nikola Vucevic, Zach Collins, Kevin Huerter and Jevon Carter are also on expiring deals for Chicago. White recently returned from a calf injury.

Collin Sexton, Charlotte Hornets

Though LaMelo Ball is the biggest name from the Hornets attached to trade deadline rumors, his max rookie extension contract is going to be difficult to move mid-season. Sexton, a veteran guard playing for a Charlotte team that appears to be resetting around rookie Kon Knueppel, would be a useful scorer and ballhandler for a contender.

Dean Wade, Cleveland Cavaliers

This season hasn’t gone as smoothly for the Cavaliers as last year, but they aren’t reportedly ready to make a drastic move. Dealing one of their smaller expiring contracts is a more likely route to shake up the rotation a bit. Lonzo Ball and DeAndre Hunter also fit the bill, but Wade might be the most valuable to move given his $6.6 million salary and versatility as a stretch big.

Anthony Davis, Dallas Mavericks

What’s a team willing to give up for the oft-injured star who’s still plenty effective when he plays? And what are the Mavericks willing to take for the centerpiece of their failed Luka Doncic trade? Those questions linger over any potential Davis deal and could make a player like fellow center Daniel Gafford the more likely trade piece for Dallas to move at the deadline. But it appears the Mavericks need to rebuild around Cooper Flagg and they can’t fully embrace that until Davis is off the roster.

Peyton Watson, Denver Nuggets

The former first-round pick has not come to terms on a contract extension with the Nuggets and he’s having the most impactful season of his career. Denver could risk losing Watson for nothing after the season if he signs elsewhere, but he’s playing an important two-way role on the wing for an NBA title contender that already made a splashy offseason move to trade for wing Cameron Johnson.

Caris LeVert, Detroit Pistons

The Pistons don’t seem eager to part with any of the young players that have led them to the top of the Eastern Conference standings, but they could use another shooter. LeVert is averaging a career low in minutes after signing with Detroit this offseason, though he’s shooting 38.4% from 3-point range on three attempts per game and has postseason experience. A recent injury to veteran Tobias Harris complicates his trade value ahead of the deadline, but his expiring contract would likely be included should the Pistons opt for a bigger move.

Jonathan Kuminga, Golden State Warriors

Kuminga doesn’t want to play for the Warriors anymore and coach Steve Kerr isn’t playing him in the team’s rotation much. A divorce seems inevitable. It’s just a matter of when. Kuminga isn’t eligible to be traded until Jan. 15 due to the contract he signed this offseason as a restricted free agent after a lengthy stalemate in negotiations. That gives Golden State three weeks to execute a deal before the trade deadline.

Clint Capela, Houston Rockets

Capela is a luxury for the Rockets when Alperen Sengun and Steven Adams are healthy and the veteran’s return to Houston coincided with his smallest role since being a Rockets rookie in 2014. But his contract is reasonable and he could net Houston some insurance on the perimeter for the playoffs. Otherwise, the Rockets already made their big move this season by acquiring Kevin Durant.

Benedict Mathurin, Indiana Pacers

The Pacers are in the midst of a lost season after last year’s NBA Finals run and they have not signed Mathurin to a contract extension despite having the opportunity to do so. It would be prudent, then, to trade him and get some value from the former first-round pick before he departs via free agency this offseason. A recent thumb injury suffered by Mathurin would limit a trade if the recovery extends for more than a month.

Ivica Zubac, Los Angeles Clippers

Though the Clippers got off to a horrific start, they’ve perked up of late with a recent six-game win streak that occurred without Zubac in the lineup. Considering their first-round pick belongs to the Oklahoma City Thunder this year, the Clippers and aggressive owner Steve Ballmer don’t appear to be tanking candidates. Zubac is the team’s best asset if it’s looking to upgrade the overall roster, but the Clippers haven’t been open to trading him in the past. The expiring contracts of John Collins, Bogdan Bogdanovic and Chris Paul could help facilitate a deal at the deadline.

Rui Hachimura, Los Angeles Lakers

The Lakers need defensive help to support a starting lineup that will presumably feature Luka Doncic, Austin Reaves and LeBron James in the postseason. Hachimura’s expiring $18 million contract is likely to be used if they swing a deal for a two-way wing.

John Konchar, Memphis Grizzlies

There’s a lot of buzz about trading Ja Morant, but the Grizzlies don’t seem as keen on dealing their star at a relative low point compared to what his reputation was a few years ago. The franchise appears more likely to stand pat than shake up its roster at the deadline, even if recent results suggest the latter is an approach worth exploring. Perhaps, however, they will try to extract a draft pick or unload an unwanted contract ‒ Konchar, at more than $6 million through next season, fits the bill ‒ by latching on as an additional trade partner on the periphery of a bigger trade.

Andrew Wiggins, Miami Heat

The Heat are considered one of the more aggressive potential landing spots should Giannis and the Bucks part ways and Wiggins’ contract would help facilitate the deal. Though the 30-year-old former No. 1 pick is set to make $30 million next season, it’s a player option that he might decline in pursuit of more guaranteed years. The Heat could treat this like an expiring contract and deal it at the deadline to a contender looking for help on the wing. Wiggins has shown this season he’s still a net positive on the court.

Kyle Kuzma, Milwaukee Bucks

Though the rumors are flying about a potential Antetokounmpo trade, a deal this offseason appears more likely than a deadline move. But the relationship between the Bucks and their star continues to be trending towards its conclusion and all of Milwaukee’s potential moves over the next month revolve around Antetokounmpo. General Manager Jon Horst is looking for help on the wing by trying to trade for Zack LaVine or Malik Monk using the likes of Bobby Portis or Kyle Kuzma, according to a recent Sports Illustrated report. Kuzma is an expiring contract next season, while Portis has a player option for the 2027-28 season.

Donte DiVincenzo, Minnesota Timberwolves

The Timberwolves reportedly want to upgrade at point guard and DiVencenzo could wind up being the bait to get a deal done around the deadline given his reasonable $12 million salary and looming status as an expiring contract. Julius Randle is another intriguing trade option, but a team could be on the hook for more than $68 million in guaranteed money since Randle has a player option for 2027-28.

Saddiq Bey, New Orleans Pelicans

The Pelicans are in the midst of another awful season and the backcourt is going to get awfully crowded once Dejounte Murray returns from a torn Achilles suffered in January 2025. But trading Murray at the trade deadline is likely to be too complicated given his uncertain return date and Jordan Poole is owed more than $34 million next season. New Orleans could sell high on Bey, a former first-round pick who’s been among the team’s few bright spots and plays a sought-after position (wing) during this trade deadline.

Guerschon Yabusele, New York Knicks

The 30-year-old 2024 Paris Olympics star from France hasn’t worked out like the Knicks hoped thus far after signing with the team this offseason. Yabusele is likely to be included in a deal if the Knicks can upgrade their bench with an additional point guard or big man.

Lu Dort, Oklahoma City Thunder

The defending NBA champions are unlikely to shake up their core by dealing the longest-tenured member of the organization at the trade deadline, but Dort is on an expiring contract with an $18 million team option the Thunder probably can’t pick up with the bill on their stars coming due. If there’s a move to make involving a rotation player, Dort would be the easiest to part with for Thunder GM Sam Presti.

Jonathan Isaac, Orlando Magic

The Magic pushed their chips in by trading for Desmond Bane this past offseason and Isaac’s role as a defensive stopper has been diminished. His contract is filled with health-related provisions that could protect a team if Isaac’s injury issues limit his ability to fulfill the final three years of his $59 million deal. The Magic could use the salary cap relief.

Kelly Oubre Jr., Philadelphia 76ers

The Sixers would love to trade Joel Embiid or Paul George, but finding a team to take on those contracts is a long shot at this point. Of Philadelphia’s five expiring deals, Oubre’s $8.3 million is the easiest to move since Quentin Grimes reportedly has a no-trade clause in his contract.

Nick Richards, Phoenix Suns

The Suns are one of the NBA’s surprise teams this season after their strategy of unloading draft capital and assets in pursuit of big stars failed on the court. For that reason alone, a significant move is unlikely (and unwarranted). But they could get something of value for Richards, who seems to be an odd man out at center with younger options Mark Williams and Khaman Maluach on the roster.

Robert Williams, Portland Trail Blazers

Dealing Jerami Grant’s contract would be ideal for the Trail Blazers. Finding a team desperate enough to potentially commit more than $70 million to Grant over the next two seasons is the challenge. Williams is an expiring contract who was a lot more effective on a contender in Boston than he has been in Portland. Injuries are always a concern with him.

Malik Monk, Sacramento Kings

The Kings are reportedly willing to trade several prominent players in order to blow up their roster, but Monk and teammate Zack Lavine are the names that come up most often. Lavine’s $48 million salary next season will make his deal tougher to execute. Monk is three years younger at half the cost and a season removed from a career year.

Jeremy Sochan, San Antonio Spurs

The former top-10 pick is a restricted free agent after this season and averaging a career-low in minutes. He could present the Spurs with the easiest path to upgrade their roster this season without mortgaging any future assets.

Ochai Agbaji, Toronto Raptors

The Raptors are emerging as a potential contender in the wide-open Eastern Conference and Agbaji’s expiring contract and decreased role this season make him a prime candidate to be on the move.

Jusuf Nurkic, Utah Jazz

Though Lauri Markannen is on a lot of wish lists this trade deadline, the Jazz have shown no signs of being willing to trade him for anything less than a blockbuster offer. Instead, Nurkic’s expiring contract could present an opportunity to add another draft asset or take a flier on a younger alternative.

CJ McCollum, Washington Wizards

The rebuilding Wizards acquired McCollum and Khris Middleton to provide some veteran guidance to a young roster and perhaps be included in a future trade. Well, the time has come. Both are on expiring contracts. McCollum is playing better and could help a contender. He’s already been linked in a potential deal for Young.

This post appeared first on USA TODAY

Ottawa Senators GM Steve Staios’ ‘state-of-the-union’ speech to local reporters last week raised eyebrows as his club tries to stay in contention for a playoff berth in the Eastern Conference.

Staios attempted to temper fan expectations, citing the club’s struggles, the parity around the league and their goaltending situation.

Meanwhile, reports from Postmedia say Staios continues to shop aggressively in the trade market seeking a right-shot defenseman and a depth forward, with the defense being the priority.

The Senators revisited their interest in Calgary Flames defenseman Rasmus Andersson, per a report. They’re not the only club interested in the 29-year-old blueliner, as the Vegas Golden Knights, Dallas Stars, Toronto Maple Leafs and Los Angeles Kings are believed to be among the suitors.

Some teams have asked Staios about prospect defensemen Carter Yakemchuk and Logan Hensler, but he doesn’t want to part with those promising youngsters. That’s understandable, as the Senators’ prospect pipeline is not as well-stocked as it once was.

Meanwhile, speculation persists over Kiefer Sherwood’s future with the Vancouver Canucks.

On Saturday, Sportsnet’s Elliotte Friedman reported the Canucks made another contract offer to the30-year-old right winger. However, he said that a significant gap remains between the two sides, adding that there’s no timetable for a trade or an agreement on a contract.

According to Ben Kuzma and Patrick Johnston of The Province, the possibility of the Canucks retaining Sherwood is “highly unlikely.” There’s not much interest in tripling his $1.5-million cap hit, and his style of play could fetch a good return from contenders such as the Dallas Stars and Boston Bruins.

Friedman also provided an update on Edmonton Oilers winger Andrew Mangiapane after he was a healthy scratch on Saturday for the second time in three games.

The Oilers signed Mangiapane to a two-year contract last July, but the 29-year-old left winger struggled to produce despite seeing top-six minutes during the first two months of this season. Being scratched from a Dec. 29 game against the Winnipeg Jets stoked speculation that he could be traded.

Friedman believes there are some clubs interested in Mangiapane, mentioning the Anaheim Ducks had been poking around. Meanwhile, David Staples of the Edmonton Journal indicated that NHL insider Frank Seravalli suggested the Winnipeg Jets and New Jersey Devils as potential trade partners.

For action-packed issues, access to the entire magazine archive and a free issue, subscribe to The Hockey News at THN.com/free. Get the latest news and trending stories by subscribing to our newsletter here. And share your thoughts by commenting below the article on THN.com or creating your own post in our community forum.

This post appeared first on USA TODAY

There’s an old saying about what NFL means for players and coaches who fail to meet expectations – Not For Long.

While there’s a short list of coaches with real staying power, the ranks of longest-tenured NFL head coaches is being rearranged this week, most notably after the Baltimore Ravens on Jan. 6 fired John Harbaugh, ending the Super Bowl-winning coach’s 18-year run with the franchise.

Harbaugh’s tenure was second-longest among active NFL coaches, behind only Mike Tomlin of the Pittsburgh Steelers. Tomlin is preparing the Steelers for an AFC wild-card showdown against the Houston Texans on Jan. 12 after Ravens kicker Tyler Loop missed the potential game-winning kick in the Steelers’ 26-24 win over the Ravens that clinched the AFC North title on Jan. 4.

Tomlin hasn’t been immune to calls for the Steelers to part ways with their longtime coach this season, but that conversation will be shelved as long as the Steelers remain Super Bowl contenders.

For now, here’s a look at the longest-tenured NFL coaches, which aside from Harbaugh was also changed by the Cleveland Browns’ firing of Kevin Stefanski (six years in Cleveland) on Jan. 5, this year’s ‘Black Monday.’

For those wondering, Curly Lambeau in Green Bay (1921-49) and Tom Landry in Dallas (1960-88) are tied for the longest tenure leading one team at 29 seasons.

1. Mike Tomlin, Pittsburgh Steelers

  • Age: 53
  • Number of seasons: 19
  • Record with Steelers (through 2025 regular season): 193-114-2 (.628)
  • Playoff berths (Super Bowls): 13 (2; won Super Bowl 43, lost Super Bowl 45)

2. Andy Reid, Kansas City Chiefs

  • Age: 67
  • Number of seasons: 13
  • Record with Chiefs: 149-64 (.700)
  • Playoff berths (Super Bowls): 10 (4; won Super Bowl 54, lost Super Bowl 55, won Super Bowl 57, won Super Bowl 58, lost Super Bowl 59)

T3. Sean McDermott, Buffalo Bills

  • Age: 51
  • Number of seasons: 9
  • Record with Bills: 98-50 (.662)
  • Playoff berths: 8

T3. Sean McVay, Los Angeles Rams

  • Age: 39
  • Number of seasons: 9
  • Record with Rams: 92-57 (.617)
  • Playoff berths (Super Bowls): 7 (2; lost Super Bowl 53, won Super Bowl 56)

T3. Kyle Shanahan, San Francisco 49ers

  • Age: 46
  • Number of seasons: 9
  • Record with 49ers: 82-67 (.550)
  • Playoff berths (Super Bowls): 5 (1; lost Super Bowl 54, lost Super Bowl 58)

T6. Matt LaFleur, Green Bay Packers

  • Age: 46
  • Number of seasons: 7
  • Record with Packers: 76-40-1 (.654)
  • Playoff berths: 6

T6. Zac Taylor, Cincinnati Bengals

  • Age: 42
  • Number of seasons: 7
  • Record with Bengals: 52-63-1 (.453
  • Playoff berths (Super Bowls): 2 (1; lost Super Bowl 56)

T8. Dan Campbell, Detroit Lions

  • Age: 49
  • Number of seasons: 5
  • Record with Lions: 48-36-1 (.571)
  • Playoff berths: 2

T8. Nick Sirianni, Philadelphia Eagles

  • Age: 44
  • Number of seasons: 5
  • Record with Eagles: 59-26 (.694)
  • Playoff berths (Super Bowls): 5 (2; lost Super Bowl 57, won Super Bowl 59)

T10. Mike McDaniel, Miami Dolphins

  • Age: 42
  • Number of seasons: 4
  • Record with Dolphins: 35-33 (.515)
  • Playoff berths: 2

T10. Todd Bowles, Tampa Bay Buccaneers

  • Age: 62
  • Number of seasons: 4
  • Record with Buccaneers: 35-33 (.515)
  • Playoff berths: 3
This post appeared first on USA TODAY

Perth, Australia (ABN Newswire) – Altech Batteries Ltd (ASX:ATC,OTC:ALTHF) (FRA:A3Y) (OTCMKTS:ALTHF) announced that binding conditional funding approval in the amount of 46.11 million Euro has now been granted for the CERENERGY(R) Sodium-Chloride Solid-State battery project in Saxony, Germany. The grant approval materially derisks project funding and supports progression toward construction of the planned 120 MWh CERENERGY(R) battery manufacturing facility in Saxony, Germany.

Highlights

– Altech Batteries GmbH’s CERENERGY(R) battery project has received conditional binding funding approval under Germany’s federal ‘STARK’ economic development program.

– The approval relates to a grant covering approximately 30% of eligible project CAPEX, with funding of up to EUR46.11M.

– The funding commitment is conditional on achieving full project financial close by 30 June 2026 and parliamentary approval of funds under Germany’s 2026 Federal Budget.

Conditional Binding Funding Commitment

The funding is being provided as part of the federal STARK program, which is supported by the Federal Ministry for Economic Affairs and Energy in cooperation with the EU. The aim of this program is to lead regions undergoing structural change into an ecologically, economically and socially sustainable future.

With the approval of the funding, the project has successfully completed the second and decisive stage of the approval process. The funding covers approximately 30% of the eligible investment costs and represents a significant milestone for the construction of the planned 120 MWh CERENERGY(R) battery factory in Germany.

This decision underscores the importance of the innovative CERENERGY(R) technology, which is being developed in collaboration with the Fraunhofer Society. The Sodium-Chloride Solid-State battery offers a safe, sustainable and strategically independent alternative to lithium-ion batteries and is expected to play an important role in future stationary energy storage solutions – especially for the European market.

Mr Daniel Raihani, Managing Director & Chief Executive Officer, commented ‘Securing conditional binding funding approval of up to EUR46.11 million under Germany’s STARK program is a major milestone for the CERENERGY(R) project. The support reflects the strategic importance of establishing advanced, nonlithium energy storage manufacturing capability in Europe and recognises the technical progress achieved to date in collaboration with Fraunhofer IKTS.

‘Importantly, the grant materially de-risks the project’s capital structure by covering approximately 30% of eligible investment costs and provides a strong foundation as we progress toward full project financing and construction of the planned 120 MWh production facility in Saxony, Germany.

‘We remain focused on completing financial close by mid-2026 and advancing the CERENERGY(R) technology toward commercial deployment to support long-duration, safe and sustainable stationary energy storage solutions for the European market’.

As is customary for projects of this size, the funding commitment is subject to final financial close of the CERENERGY(R) battery project by June 2026 and budgetary approval of the funds in the 2026 federal budget.

*To view tables and figures, please visit:
https://abnnewswire.net/lnk/918BT5H8

About Altech Batteries Ltd:

Altech Batteries Limited (ASX:ATC,OTC:ALTHF) (FRA:A3Y) is a specialty battery technology company that has a joint venture agreement with world leading German battery institute Fraunhofer IKTS (‘Fraunhofer’) to commercialise the revolutionary CERENERGY(R) Sodium Alumina Solid State (SAS) Battery. CERENERGY(R) batteries are the game-changing alternative to lithium-ion batteries. CERENERGY(R) batteries are fire and explosion-proof; have a life span of more than 15 years and operate in extreme cold and desert climates. The battery technology uses table salt and is lithium-free; cobalt-free; graphite-free; and copper-free, eliminating exposure to critical metal price rises and supply chain concerns.

The joint venture is commercialising its CERENERGY(R) battery, with plans to construct a 100MWh production facility on Altech’s land in Saxony, Germany. The facility intends to produce CERENERGY(R) battery modules to provide grid storage solutions to the market.

Source:
Altech Batteries Ltd

Contact:
Daniel Raihani
Managing Director
Altech Batteries Limited
Tel: +61-8-6168-1555
Email: info@altechgroup.com

Martin Stein
Chief Financial Officer
Altech Batteries Limited
Tel: +61-8-6168-1555
Email: info@altechgroup.com

News Provided by ABN Newswire via QuoteMedia

This post appeared first on investingnews.com

Here’s a quick recap of the crypto landscape for Monday (January 5) as of 9:00 p.m. UTC.

Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news.

Bitcoin and Ether price update

Bitcoin (BTC) was priced at US$94,127.01, up by 3.2 percent over 24 hours.

Bitcoin price performance, January 6, 2025.

Chart via TradingView.

Bitcoin started Monday strong, rising above US$92,000 in early trading before briefly breaking US$94,600, signaling a potential shift in near-term momentum after a bruising finish to 2025.

Research firm 10X said the move reflects a return to more normalized trading volumes and early signs of renewed institutional positioning at the start of the year. The firm notes that Bitcoin is holding above key moving averages, with the 21 day line emerging as a critical support level for maintaining upside bias.

It added that the shift suggests growing expectations for a push toward the US$100,000 level. The rebound follows three consecutive monthly declines — a historically rare pattern that has often preceded January recoveries.

“The strength across crypto and traditional safe havens reflects a rebalancing phase driven by geopolitical risk and liquidity positioning,” said Lacie Zhang, a research analyst at Bitget Wallet.

“In this setup, Bitcoin has room to push toward US$105,000, while Ethereum could test US$3,600, as traders balance inflation risks with crypto’s deflationary characteristics and long-term adoption narrative.’

Zhang said DeFi is currently driving significant growth, with protocols such as Uniswap (UNI) and Aave (AAVE) seeing benefits from improved governance, new revenue-sharing frameworks and institutional investor involvement.

“For large-cap altcoins, XRP and Solana stand out: XRP’s role in cross-border payments and improving regulatory clarity, combined with ETF inflows, could support price ranges of US$5 – US$10, while Solana’s high-throughput ecosystem and network expansion position it for US$500 – US$800 over the next growth phase.

“The renewed surge in memecoin activity reflects improving retail risk appetite,” she added. “It’s not a long-term thesis, but often a precursor to liquidity rotating into higher-quality, utility-driven altcoins as the cycle matures.”

Ether (ETH) was priced at US$3,239.82, up by 3.2 percent over the last 24 hours.

Altcoin price update

  • XRP (XRP) was priced at US$2.31, up by 10.4 percent over 24 hours.
  • Solana (SOL) was trading at US$137.92, up by three percent over 24 hours.

Today’s crypto news to know

Crypto investment products pull in US$47.2 billion in 2025

Global crypto exchange-traded products attracted US$47.2 billion in net inflows in 2025, falling just short of the prior year’s record despite a noticeable slowdown in Bitcoin demand, according to CoinShares.

Bitcoin-focused products added US$26.9 billion, a sharp drop from 2024 levels, as price weakness dampened inflows and modest interest emerged in short-bitcoin vehicles. The cooling in Bitcoin was offset by a surge into select altcoins, led by Ethereum products, which posted US$12.7 billion in inflows.

Meanwhile, XRP and Solana funds followed closely as each recorded multibillion-dollar inflows and triple-digit percentage growth year over year.

Japan signals crypto integration across traditional markets

Satsuki Katayama, Japan’s finance minister, has signaled stronger government backing for integrating digital assets into the country’s stock and commodities exchanges.

Speaking at the Tokyo Stock Exchange, she emphasized the role of exchanges in expanding public access to blockchain-based assets and modern investment tools. She pointed to the US experience with crypto-linked exchange-traded funds (ETFs) as a reference point, even as Japan currently lacks domestically listed crypto ETFs.

Katayama described 2026 as a “digital year,” pledging policy support for exchanges adopting advanced trading technologies. The remarks build on regulatory reforms already underway, including discussions on allowing banks to hold crypto assets and the approval of Japan’s first yen-pegged stablecoin.

Bitget’s tokenized stock milestone and TradFi launch

Bitget’s new Universal Exchange vision has reached two major milestones that signal a major shift in how digital and traditional assets are traded in one place. Bitget announced last week that its tokenized stock volume surpassed US$1 billion, with 95 percent of that total volume occurring in December alone.

Building on that momentum, and following a successful private beta with over 80,000 users, today Bitget officially opened its TradFi trading suite to the public, allowing customers access to 79 different instruments across forex, metals, indices and commodities. These products are traded as contracts for difference and are settled entirely in USDT, meaning crypto-native traders can execute macro strategies without leaving the platform or converting to fiat currency.

During the test phase, XAU/USD recorded over US$100 million in single-day trading volume, one of the highest daily figures observed during the beta.

“Traders want the flexibility to choose between assets in a unified ecosystem,” said Chen.

“They want the freedom to move between crypto and traditional markets as conditions change. TradFi going public is about giving them that accessibility in one place, without friction.”

The move signals a broader shift in how exchanges are evolving, not just as venues for speculation, but as comprehensive gateways to global markets under a unified trading experience.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

From established players to up-and-coming firms, Canada’s pharmaceutical landscape is diverse and dynamic.

Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well.

Read on to learn about what’s been driving the share prices of the best-performing Canadian pharma stocks.

1. HLS Therapeutics (TSX:HLS)

Year-on-year gain: 26.6 percent
Market cap: C$149.8 million
Share price: C$4.76

HLS Therapeutics focuses on drugs for cardiovascular and central nervous system problems, often through partnerships. The company specializes in acquiring and commercializing pharmaceuticals that address unmet needs, including Vascepa to reduce cardiovascular risk and Clozaril for treatment-resistant schizophrenia.

HLS in-licensed the exclusive rights to the treatments Nilemdo and Nexlizet, both of which are already approved in other countries, from Esperion (NASDAQ:ESPR) in May.

The November 2025 Health Canada approval of LDL-cholesterol lowering treatment Nilemdo represents the most significant catalyst for the company since the launch of Vascepa, positioning HLS as a dominant leader in the Canadian cardiovascular market. The company is targeting Nilemdo’s commercial launch in Q2 2026.

Along with the approval, Health Canada issued a notice of non-compliance for its Nexlizet cholesterol-reducing treatment. According to HLS, the decision was related to chemistry, manufacture and controls data, not clinical data or safety.

Additionally, the company generates revenue from a diversified portfolio of royalty interests on various products marketed by third parties.

2. Satellos Bioscience (TSXV:MSCL)

Year-on-year gain: 14.49 percent
Market cap: C$141.04 million
Share price: C$0.79

Satellos Bioscience is a Canadian pharmaceutical company expanding treatment options for muscle disorders. The company has focused specifically on Duchenne muscular dystrophy, developing therapies that target the specific biological pathways involved in regenerating and repairing muscle tissue.

Its lead candidate, SAT-3247, targets a protein called AAK1, which regulates the activity of stem cells that activate and differentiate new muscle fibers.

In Q4 2025, Satellos administered the first dose to a patient in its 11-month open-label follow-up study for adults who completed its initial Phase 1b trial. The study seeks to demonstrate the lasting impact of the significant functional improvements observed earlier in the year.

On December 9, the company received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) and several other global regulators to initiate BASECAMP, a global Phase 2 randomized, placebo-controlled study to evaluate SAT-3247 in pediatric patients.

3. Knight Therapeutics (TSX:GUD)

Year-on-year gain: 14.29 percent
Market cap: C$592.59 million
Share price: C$6.00

Knight Therapeutics is a specialty pharmaceutical company headquartered in Montreal, Québec. It operates on an acquisition and in-licensing model, obtaining the rights to innovative medicines from global pharmaceutical companies and commercializing them across Canada and Latin America.

The company was originally founded by the former leaders of Paladin Labs, which was acquired by Endo International in 2014. In June 2025, Knight bought the Paladin business back from Endo for C$107 million, adding over 40 products to Knight’s Canadian roster.

The additions, helped drive 32 percent revenue growth year-over-year to a record C$122.55 million in Q3. The company projects its Knight Canada subsidiary will be the company’s top revenue-contributor within two years.

4. BioSyent (TSXV:RX)

Year-on-year gain: 10.07 percent
Market cap: C$146.89 million
Share price: C$12.90

BioSyent is a specialty pharmaceutical company focused on in-licensing or acquiring established, high-margin healthcare products for the Canadian and international markets. Its growth is anchored by brands in iron health and women’s wellness. Its flagship brand, FeraMAX, has been Canada’s leading iron supplement for over a decade.

The company’s 2024 acquisition of Tibella, a treatment for menopausal symptoms, has been a major growth driver. According to its Q3 earnings report. BioSyent’s sales grew 19 percent year-over-year in Canada and 94 percent in the international market.

5. NurExone Biologic (TSXV:NRX)

Year-on-year gain: 6.45 percent
Market cap: C$47.54 million
Share price: C$0.66

NurExone Biologic is behind ExoTherapy, a drug-delivery platform that uses exosomes, which are nano-sized extracellular vesicles, to create treatments for central nervous system disorders, spinal cord injuries and traumatic brain injuries. It is a less invasive alternative to cell transplantation, which requires surgery and carries the risk of rejection.

NurExone’s first nano-drug, ExoPTEN, uses a proprietary sIRNA sequence delivered with the ExoTherapy platform to treat spinal cord injuries. ExoPTEN received orphan drug designation from the US FDA in October 2023.

The company expects to initiate its Phase 1/2a first-in-human trial for acute spinal cord injury in the second half of 2026, targeting patients with traumatic injuries.

It continues to make significant progress, with recent preclinical studies demonstrating strong, dose-dependent vision recovery in glaucoma models and improved motor function in spinal cord injury models.

The company announced plans for a US exosome production facility in Indianapolis, Indiana, in September. According to the release, ‘The GMP compliant site would produce exosomes both for NurExone’s therapeutic pipeline and for a growing business-to-business opportunity in regenerative aesthetics.’

In December, the company began planning for small-scale production of ExoPTEN in Israel to support its clinical trial.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Investor Insight

Centurion Minerals offers investors an early-stage entry point into a strategically located gold exploration company positioned within one of North America’s most prolific and active mining districts. With a restructured corporate foundation, and a highly experienced geological and corporate finance team, the company is primed for value-creating discoveries.

investingnews.com

Overview

Centurion Minerals (TSXV:CTN) is a Canadian exploration company focused on the acquisition, exploration and development of precious metals projects in the Americas.

The company’s strategy is centered on advancing high-quality, early-stage gold assets through systematic exploration to define drill-ready targets and unlock the discovery potential inherent in its three-part claim package: the Newman, Noseworthy and Hepburn properties. Situated near major operations and new discoveries, these claims benefit from excellent infrastructure, year-round road access and proximity to proven mineralized structural corridors. Centurion intends to increase shareholder value through targeted geophysics, ground truthing and drilling programs designed to reveal new high-grade zones, as well as through potential future acquisitions of complementary gold assets across the Americas.

Backed by a leadership team with decades of exploration, geology, corporate finance and project development experience, Centurion is positioned to capitalize on strong gold market fundamentals and renewed investor interest in junior exploration companies. With a low current valuation and advancing work program, the company provides leverage to both exploration success and broader trends in the gold sector.

Company Highlights

  • Highly prospective gold project in a world-class district located in the central north Abitibi greenstone belt, adjacent to major deposits and producing mines including Hecla Mining’s (NYSE:HL) Casa Berardi mine and Agnico Eagle’s (TSX:AEM) Detour Lake operations.
  • Exceptional closeology advantage, with its Casa Berardi West project situated just 12 km from AMEX Exploration’s (TSXV:AMX) 1.6 Moz “Perron” discovery and along the same structural corridors that have produced multi-million-ounce deposits.
  • Significant historic drilling across the three claim groups, including results up to 38 g/t gold and multiple intervals indicating gold-bearing iron formations and shear zones.
  • Clear exploration strategy including historic data compilation, geophysical surveys, target generation and a planned program to define new mineralized zones.
  • Experienced management and technical team with decades of experience in mineral exploration, and international corporate finance, enhances the potential of uncovering additional exploration opportunities.
  • Low market capitalization and recently reactivated corporate structure, offering investors a low entry point ahead of meaningful upside catalysts.

Key Project

Casa Berardi West Gold Project

The Casa Berardi West project is Centurion’s flagship gold exploration asset, encompassing approximately 6,732 hectares across three contiguous claim groups – Newman, Noseworthy and Hepburn – located 66 km northeast of Cochrane, Ontario. The project sits along structural corridors that host some of the region’s most significant deposits, including Hecla Mining’s Casa Berardi mine (3 Moz past production, plus 4 Moz in reserves and resources), Agnico Eagle’s Detour Lake mine (15 Moz reserve, producing ~659,000 oz of gold per year ), and AMEX Exploration’s Perron discovery (1.6 Moz measured and indicated resource at 6.14 g/t gold).

Location of the three claim groups at Casa Berardi West

Geological Setting & Closeology Advantage

The project is situated within the central north Abitibi Subprovince, an Archean greenstone belt known globally for its prolific endowment of gold and base metals. The claims lie adjacent to geological features associated with multiple major deposits – iron formations, shear zones and VMS trends – creating strong analogues to high-grade gold mines such as the Musselwhite mine in Northern Ontario.

This “closeology” positioning significantly enhances the potential for Centurion’s ground to host similar mineralization.

Historic Results & Target Areas

Historic exploration across the Casa Berardi West project – spanning more than 70 RC and diamond drill holes – has already confirmed the presence of gold-bearing structures and favorable host rocks. Notably, previous work returned multiple samples above 1 g/t gold, including a standout result of 38 g/t gold, demonstrating strong mineralization potential across the claim area.

Significant historic drill results at Newman target

Across the three claim groups, drilling and geophysical surveys have identified key geological features associated with major deposits in the region, including iron formations, shear zones and sulphidized horizons. Several zones of interest remain untested or underexplored, particularly along structural trends that extend from nearby high-grade gold and VMS systems such as the Perron and Normetal areas.

These findings provide Centurion with multiple high-priority target areas for follow-up exploration, forming the foundation for its next phase of geophysical work and upcoming drill targeting.

Management Team

David Tafel – Director, President and CEO

David Tafel brings over 30 years of experience in corporate structuring, strategic planning, financing and executive management across multiple public and private resource companies. He has raised several hundred million dollars for ventures in mining, technology and life sciences, and previously managed private investment funds at Canada’s largest independent securities firm.

Jeremy Wright – Director and CFO

A seasoned financial executive with more than 20 years of experience, Jeremy Wright serves as president & CEO of Seatrend Strategy Group and has held CFO roles across numerous public companies in the resource and technology sectors. His background includes financial management, negotiations and environmental economics, supported by extensive board leadership experience.

Joseph Del Campo – Director

Joseph Del Campo has served as CFO and Interim CEO across several mining companies, including Unigold and First Nickel. With decades of corporate financial leadership and board experience, he contributes deep governance, audit and operational oversight expertise to Centurion’s board.

Mike Kilbourne – Geological Consultant

A veteran geologist with 40+ years of industry experience, Mike Kilbourne has managed over 100,000 metres of drilling across North America and Mexico, worked as a production geologist in multiple mining environments, and generated over 700 exploration targets for private and public companies.

Jamie Lavigne – Geological Consultant

Jamie Lavigne is a senior exploration geologist with more than 30 years of experience in base and precious metals. He has held senior technical roles with major mining companies and specializes in advanced exploration, resource delineation and geological modeling across global mineral belts.

This post appeared first on investingnews.com

MILWAUKEE, WI —The U.S. Speedskating team is complete.

Sarah Warren, who narrowly missed the Olympic team four years ago, secured her spot at the Milano Cortina Games by winning the 500-meter race on Monday night. She was one of four skaters added to the U.S. team in the final day of the Olympic trials.

Zach Stoppelmoor qualified in the 500 meters; Ethan Cepuran got a spot in the mass start; and Giorgia Birkdale was nominated as a team pursuit specialist. They join:

  • Jordan Stolz (500, 1,000, 1,500 meters and mass start)
  • Cooper McLeod (500 and 1,000 meters)
  • Casey Dawson (1,500, 5,000, 10,000 meters and team pursuit)
  • Emery Lehman (1,500 meters and team pursuit)
  • Conor McDermott-Mostowy (1,000 meters)
  • Erin Jackson (500 and 1,000 meters)
  • Brittany Bowe (1,000 and 1,500 meters)
  • Mia Manganello (mass start and team pursuit)
  • Greta Myers (1,500 meters and team pursuit)

Stolz will be a gold-medal favorite in all of his events, while the men’s team pursuit also will be favorites for gold. Jackson and Bowe will be contenders at both of their distances, while Mia Manganello has a chance to medal in the mass start. The women’s team pursuit also has medal potential.

‘I think it’s really good,’ Stolz said when asked to assess the team. ‘I think we have some good (medal) opportunities.’

Warren earning her spot was one of the more emotional moments of the night.

After playing soccer at the University of Illinois, Warren returned to speed skating in 2021. She nearly made the U.S. team for the 2022 Olympics in Beijing, finishing fourth in the 500 meters and fifth in both the 1,000 and 1,500 meters.

She’s had nine knee surgeries over the course of her career, and another on her ankle.

Jackson, the reigning Olympic champion in the 500 meters, had pre-qualified her spot through her success in the World Cups this season. The person with the next-fastest time after a 500-meter race Sunday and another Monday would join her.

Warren was second to Jackson on Sunday. With Jackson not racing Monday, Warren posted the fastest time to clinch her Olympic spot. When she crossed the finish line, Warren screamed and began crying.

The 2026 Milano Cortina Winter Olympics are coming! Sign up for our Chasing Gold newsletter.

This post appeared first on USA TODAY

NCAA women’s hockey returned in full force following the holiday break.

Dozens of games were on the schedule, including Minnesota-Duluth, Harvard, Quinnipiac and Boston University facing off in Belfast, Northern Ireland, as part of the Friendship Series.

Teams are in their final stretch before many of the top players in NCAA women’s hockey travel to Italy for the 2026 Olympics, a departure that will significantly affect some of the top programs in the nation. With that change coming, teams wasted no time fighting for positioning in the standings as they returned to action.

Here’s a look at the top 10 NCAA women’s hockey programs this week:

Women’s college hockey power rankings

1. University of Wisconsin (WCHA)

The powerhouse program didn’t play, but it did see Laila Edwards, Kirsten Simms, Caroline Harvey and Ava McNaughton named to USA’s Olympic women’s hockey team. They will face Minnesota-Duluth, which is coming off a pair of disappointing losses in Europe this week, which should tip the scales further in Wisconsin’s favor. Until someone proves otherwise, the Badgers look like the team to beat.

2. Ohio State University (WCHA)

Ohio State swept the top team from Atlantic Hockey America, Penn State, handing the Nittany Lions their second and third losses of the season. Ohio State showed the WCHA’s dominance, outshooting No. 4 Penn State 85-45 in the two-game series, earning 4-1 and 5-1 wins. Senior Sloane Matthews, who will enter the 2026 PWHL Draft, led the way offensively with two goals and four points.

3. University of Minnesota (WCHA)

Minnesota had a walk in the park facing Sacred Heart. They set a program record, scoring 14 goals in the second game of their series and outscoring the NEWHA program 18-2. The series allowed American national team member Abbey Murphy to catapult into the national scoring lead as she recorded nine points in Minnesota’s lopsided wins.

4. Penn State (Atlantic Hockey America)

Penn State failed to hold their ground against Ohio State but also weren’t completely outplayed in their series loss despite being outscored 9-2 across two games. Tessa Janecke and Maddy Christian, in particular, were threats for Penn State. The Nittany Lions vastly improved in the second game, a 4-1 loss to Ohio State. If it were not for a trio of power-play goals by the Buckeyes, things could have been different.

5. Quinnipiac (ECAC)

Playing in Northern Ireland, Quinnipiac skated to a 2-2 tie against Boston University, before a shootout sent BU to the final and the Bobcats to a third-place matchup against Minnesota-Duluth. In the third-place game, the Bobcats responded by upsetting Minnesota-Duluth. Quinnipiac was backed by strong netminding from Felicia Frank and the offensive play of Kahlen Lamarche, who sits second in the nation in goals with 23.

6. University of Minnesota-Duluth (WCHA)

Minnesota-Duluth struggled to find their way through the jet lag of travelling to Belfast for the Friendship Series. They fell in overtime to unranked Harvard, then dropped a 3-1 decision to Quinnipiac. Scoring has remained an issue for the Bulldogs this season as they’ve recorded only 58 goals, tied for 14th in the nation.

7. Northeastern (Hockey East)

Northeastern didn’t play, but they’ll face Yale in an upcoming midweek game and have the historic Beanpot approaching. Captain Lily Shannon is having a season to remember, vaulting herself up the PWHL draft charts, while young stars including Stryker Zablocki, Lisa Jonsson, Alessia Baechler, Eloise Caron and Morgan Jackson continue to show that Northeastern is a program that will continue to improve this season and into the future.

8. Cornell (ECAC)

Cornell’s lone game following the holiday break was a tightly contested 1-0 loss to Penn State. Cornell outshot Penn State 35-32 in the loss, but couldn’t solve Katie DeSa in net. It wasn’t until Lindzi Avar took a five-minute major for hitting from behind late in the game that Penn State capitalized on the power play with only 4:24 remaining to decide the game.

9. Princeton (ECAC)

Princeton had an easy weekend, outscoring Stonehill 18-1 in a pair of wins. More important than the wins was the chance for Princeton’s top players to gain confidence heading into the final stretch. Issy Wunder had five goals and nine points in the series, while Mackenzie Alexander had five goals and eight points. 

10. Connecticut (Hockey East)

UConn easily handled Providence, sweeping their weekend series. Tia Chan was spectacular in net, stopping 62 of 63 shots, including a 31-save 5-0 shutout to conclude the series. UConn has been waiting for the duo of Claire Murdoch and Julia Pellerin to heat up this season, and they showed positive signs this weekend, with Murdoch scoring in both games and Pellerin recording a goal and three assists.

This post appeared first on USA TODAY